We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other best ...
BD, Medtronic and Abbott were among the top 10 medical device manufacturers with the highest number of late reports, the ...
We are thrilled to announce our collaboration with Abbott, integrating its world-leading FreeStyle Libre technology 2 as our first CGM partner, marking a significant milestone as we bring our ...
In most cases, Abbott is one of three or four competitors that dominate the market, including nutrition, cardiac rhythm management devices, surgical heart valves, continuous glucose monitors, coronary ...
1d
Zacks Investment Research on MSNAbbott Laboratories Gains 12.7% in a Year: What's Driving the Stock?Abbott Laboratories ABT has witnessed strong momentum in the past year. Shares of the company have risen 12.7% compared with the 9% growth of the industry during the same time frame. The S&P 500 ...
1d
TipRanks on MSNAvanos Medical Appoints David Pacitti as New CEOAn update from Avanos Medical ( ($AVNS) ) is now available. On March 17, 2025, Avanos Medical announced the appointment of David Pacitti as its ...
Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...
Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.
Abbott EVP Lisa Earnhardt's pay increased 19% to $6.6 million as her medical device group's sales grew by 12%.
Mehmet Oz, President Trump’s pick to lead the CMS, said Medicare beneficiaries should have quicker access to new medical ...
Nearly 10% of postmarket device safety reports in MAUDE were submitted over 6 months after the safety event occurred.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results